Teshamae Monteith, MD, FAAN
Associate Editor of
Associate Professor of Clinical Neurology, University of Miami Miller School of Medicine, Miami, Florida
Relationship Disclosure: Dr Monteith has received personal compensation in the range of $0 to $499 for serving as a consultant for AbbVie Inc; in the range of $500 to $4999 for serving as a consultant for Impel, Linpharma Inc, Lundbeck, and Novartis Pharmaceuticals Corporation, for serving on a scientific advisory or data safety monitoring board for Alder Biopharmaceuticals, Lundbeck, and Teva Pharmaceutical Industries Ltd, for serving as an editor, associate editor, or editorial advisory board member for the American Academy of Neurology, for serving as an educator with Academic CME, the Massachusetts Medical Society, and Medscape, and for serving as a speaker with Neurodiem; and in the range of $10,000 to $49,999 for serving as an educator with Rockpointe Corporation. Dr Monteith has noncompensated relationships as president-elect with the Florida Society of Neurology, as an editorial board member with American Migraine Foundation, as a board member with the International Headache Society, and as an author with AbbVie Inc, Pfizer Inc, and Theranica Bio-Electronics Ltd that are relevant to the American Academy of Neurology interests or activities. The institution of Dr Monteith has received research support from AbbVie Inc, Amgen Inc, electroCore, Inc, Lilly, Novartis Pharmaceuticals Corporation, and Teva Pharmaceutical Industries Ltd.